Cardio-Oncology

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series

Sarju Ganatra, Anju Nohria, Sachin Shah et al. · 2019 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Vanesa Gregorietti, Teresa López‐Fernández, Diego Costa et al. · 2020 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures

Anthony F. Yu, Lee W. Jones · 2016 · 56 citations · Full text

Medicine, Kinesiology, Oncology +17

Cardiotoxicity after cancer treatment: a process map of the patient treatment journey

Robyn Clark, Tania Marin, Alexandra McCarthy et al. · 2019 · 44 citations · Full text

Medicine, Cardiology, Oncology +16

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group

Lisa M. Kopp, Richard B. Womer, Cindy L. Schwartz et al. · 2019 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17